Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2010
10/06/2010CN101855236A Detection and quantitation of urine gelsolin
10/06/2010CN101854951A Formulations for TACI-immunoglobulin fusion proteins
10/06/2010CN101854950A Donor specific antibody libraries
10/06/2010CN101854949A Methods and compositions for modulating t cells
10/06/2010CN101854945A Ctl inducer composition
10/06/2010CN101851636A Recombinant influenza viruses for vaccines and gene therapy
10/06/2010CN101851631A Codon-optimized EV71 VP1 gene and nucleic acid vaccine
10/06/2010CN101851609A Porcine parvovirus L strain and use thereof in preparation of porcine parvovirus inactivated vaccines
10/06/2010CN101851291A Heavy chain and light chain variable regions of anti-human BAFF monoclonal antibody
10/06/2010CN101851289A Humanized antibody of H5 subtype avian influenza virus hemagglutinin and application thereof
10/06/2010CN101851279A Pseudomonas aeruginosa antigens
10/06/2010CN101851275A Dimerized peptide
10/06/2010CN101850117A Compound immunological adjuvant and vaccine
10/06/2010CN101850116A Method for constructing virus live vector recombinant vaccine by utilizing transposon
10/06/2010CN101850115A Method for producing swine fever live vaccine by using porcine kidney cell line (IBRS-2) and product thereof
10/06/2010CN101850114A Method for producing swine fever live vaccine by using porcine kidney cell line (PK15) and product thereof
10/06/2010CN101850113A Vaccine for preventing porcine reproductive and respiratory syndrome
10/06/2010CN101850112A Novel recombinant vaccine used for preventing tuberculosis
10/06/2010CN101850111A Novel vaccine used for preventing tuberculosis
10/06/2010CN101334356B Gas sensors
10/06/2010CN101113163B Hla-a24-restricted cancer antigen peptides
10/05/2010US7809428 Devices for detection and therapy of atheromatous plaque
10/05/2010US7807810 Nucleic acids encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby
10/05/2010US7807805 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
10/05/2010US7807803 For prophylaxis and therapy of infectious disease, allergy, cancer
10/05/2010US7807797 Human cytotoxic T-lymphocyte antigen 4 (CTLA-4); heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4; administering an antibody or antigen-binding portion to treat a tumor
10/05/2010US7807795 Antibodies to osteoprotegerin binding proteins
10/05/2010US7807793 Antiallergenics; reducing eosinophil inflammation as antiproliferation agents of IL5 secreting cells and inhibiters of adherence mechanism
10/05/2010US7807792 Wilms tumor protein-1 (WT1) for use in treatment and prevention of celll proliferative disorders; antitumor agents
10/05/2010US7807784 Immunosuppression of lymphocytes by introducing a cDNA molecule encoding mutant LIGHT into the tumor, and expressing the cDNA molecule; antitumor agents, tumor antigens; drug screening
10/05/2010US7807621 end capped sequence OCTAPEPTIDE; ANTITUMOR AGENT; antiproliferative agent; angiogenesis inhibitors
10/05/2010US7807463 Pretreatment of animal with antibodies to sensitize animal; controlling dosage
10/05/2010US7807445 Antibiotic compound
10/05/2010US7807441 Nucleotide sequences which code protein that induces cytotoxic T-lymphocyte immunity against weak selfproteins; antitumor agents
10/05/2010US7807439 detection of Staphylococcus aureus and/or for the discrimination of coagulase-positive Staphylococcus compared to coagulase-negative Staphylococcus, making it possible to isolate bacteria of the staphylococcus genus and to identify the species Stap
10/05/2010US7807412 Using platelete derived growth fator as tool in detection of modulators for prevention and treatment of cell proliferative disorders
10/05/2010US7807405 Drug delivery; drug targetting
10/05/2010US7807395 Method for the determination of prosthetic infections
10/05/2010US7807390 G-protein coupled receptor ligands and methods
10/05/2010US7807384 Drug screening; identifying a candidate agent that inhibits the binding of low density lipoprotein binding protein-2 (LBP-2) to an LBP-2 binding molecule
10/05/2010US7807380 antibodies that specifically bind to native proBNP; method of correlating the level of native proBNP to the diagnosis of heart failure, a kit for detection of native proBNP and to a hybridoma cell line producing an antibody to native proBNP; biomarkers
10/05/2010US7807377 Method of isolating antigen-specific T cells employing artificial antigen presenting cells
10/05/2010US7807355 drug screening; identifying a therapeutic for decreasing intraocular pressure raised due to frizzled related protein (FRP) overexpression; contacting a trabecular meshwork cell expressing a Wnt pathway component or a frizzled related protein gene product with a test compound
10/05/2010US7807187 Endogenous adjuvant molecules and uses thereof
10/05/2010US7807186 Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines
10/05/2010US7807185 applying to skin or mucous membrane of a mammal a composition comprising an extracellular product of a Pseudomonas lindbergii strain, an extracellular product of a Bacillus coagulans strain, and an anti-fungal agent selected from Amphotericin B, Carbol-Fuchsin, Ciclopirox, for example
10/05/2010US7807184 Heat resistant, chimeric verotoxin subunits for use in developing vaccine for prevention and treatment of microorganismal infection
10/05/2010US7807183 Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
10/05/2010US7807182 assaying biological fluid sample from subject having symptoms of active tuberculosis for presence of early antibodies specific for a 27 kDa mycobacterial tuberculosis protein named MPT51
10/05/2010US7807181 Genetic engineered mutants lipid
10/05/2010US7807180 inducing an immune response to a poxvirus in a mammal by administering a composition comprising a nucleic acid molecule comprising nucleotide sequence encoding a variola F8 polypeptide, wherein nucleotide sequence is codon optimized for expression in both a mammalian cell and a bacterial cell
10/05/2010US7807176 Polypeptide promoting vascular endothelial cell growth
10/05/2010US7807175 Therapeutic vaccine
10/05/2010US7807174 Class of therapeutic protein based molecules
10/05/2010US7807173 Avian influenza; Hemagglutinin
10/05/2010US7807172 Methods and compositions for detecting thyroglobulin in a biological sample
10/05/2010US7807171 Conjugates comprising amino acid sequences derived from extracellular loop of P170 protein; each peptide having multiple fatty acid attachments and virosomes or liposomes; inducing anti P170 antibodies; synthesis
10/05/2010US7807170 Modulating an immune response in a subject by administering an effective amount of a lymphocyte differentiation factor; antiinflammatory agents
10/05/2010US7807169 Stratified and cryogenically stored vaccines, process for their preparation
10/05/2010US7807168 Selection of human TNFα specific antibodies
10/05/2010US7807167 using an agent that specifically binds to an alpha-4 integrin or a dimer comprising an alpha-4 integrin; treatment of multiple sclerosis or inflammatory disease of the gastrointestinal tract
10/05/2010US7807166 Stimulating remyelination of central nervous system axons by administering a monoclonal antibody characterized by their ability to bind structures and cells within the central nervous system, including oligodendrocytes; including neural dysfunction caused by spinal cord injury
10/05/2010US7807165 comprises an Fc region having impaired effector function; treating a disease characterized by aberrant deposition of a protein in the brain of a subject; Alzheimer's disease, Down's syndrome, cerebral amyloid angiopathy
10/05/2010US7807163 Antibodies against GPR64 and uses thereof
10/05/2010US7807162 Single domain VHH antibodies against von Willebrand factor
10/05/2010US7807161 Humanized anti-human osteopontin antibody
10/05/2010US7807160 monoclonal antibody, or antigen binding fragment thereof that binds to human IL-23p19 at an epitope comprising residues 133-140 of SEQ ID NO: 29; treatment of inflammatory, autoimmune, and proliferative disorders
10/05/2010US7807159 Antibodies to myostatin
10/05/2010US7807158 antibody binding to IL-13R alpha 1, inhibiting IL-13 bioactivity; comprising variable heavy and light chain amino acid sequences CDR1, CDR2, and CDR3; useful in the treatment of asthma and allergic diseases
10/05/2010US7807157 Monoclonal antibodies and use thereof
10/05/2010US7807156 Administering an amount of an antibody that specifically binds to OX40 ligand (OX4L) sufficient to reduce or inhibit a recall immune response in the pulmonary tissue, or respiratory tract of the mammalian subject; asthma
10/05/2010US7807155 IL-17 antagonistic antibodies
10/05/2010US7807154 Leptin antagonist and method for quantitative measurement of leptin
10/05/2010US7807153 Apo-2 receptor agonist antibodies
10/05/2010US7807149 treatment of a bacterial infection characterized by biofilm formation; for Pseudomonas aeruginosa infections such as those in canine ears
10/05/2010US7807147 Tumor therapy with high affinity laminin receptor-targeted vectors
10/05/2010US7807139 Use of outer membrane protein A (OMPA) in treatment/prevention/diagnosis of infections caused by Klebsiella pneumoniae and other gram-negative bacteria
10/05/2010US7807134 BBN[7-13] peptide as targeting molecule, paclitaxel as therapeutic agent, a polyethylene glycol linker, a lysine or diamino benzoic acid core molecule, biotin as scaffold binding element and streptavidin as the scaffold moiety; anticarcinogenic agents; improved pharmacokinetics; intraveinous injection
10/05/2010US7807133 Diagnosis, therapy of tumors; as compared to avidin, the diavidins have shown ability to increase amount of labelled biotin on target, when used in an in vitro pretargeting test using supported human tenascin, the biotinylated anti-tenascin monoclonal antibody (Mab-B), avidin/diavidin, and biotin-3H
10/05/2010CA2436233C Perylenequinones for use with immunotherapy agents
10/05/2010CA2086325C Ligand for cd28 receptor on b cells and methods
09/2010
09/30/2010WO2010111702A1 Methods for preventing and treating angioedema
09/30/2010WO2010111687A2 Methods and compositions for immunization against virus
09/30/2010WO2010111671A1 Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications
09/30/2010WO2010111625A1 Compositions and methods for using multispecific-binding proteins comprising an antibody-receptor combination
09/30/2010WO2010111586A2 Mucosal immunization
09/30/2010WO2010111516A2 Compositions and methods for inhibiting biofilms
09/30/2010WO2010111514A1 Rapid antemortem detection of infectious agents
09/30/2010WO2010111378A1 Membrane evaporation for generating highly concentrated protein therapeutics
09/30/2010WO2010111367A1 Anti-fgfr3 antibodies and methods using same
09/30/2010WO2010111292A1 Treatment of cancer with immunostimulatory hiv tat derivative polypeptides
09/30/2010WO2010111273A1 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
09/30/2010WO2010111254A1 Novel anti-alpha5beta1 antibodies and uses thereof
09/30/2010WO2010111018A1 Antibody drug conjugates (adc) that bind to 24p4c12 proteins
09/30/2010WO2010110931A2 Glycoconjugate vaccines
09/30/2010WO2010110838A2 Antibody constant domain regions and uses thereof
09/30/2010WO2010110737A1 Monoclonal antibody against a conserved domain of m2e polypeptide in influenza viruses
09/30/2010WO2010110455A1 Polyion complex comprising hydrophobized polyamino acid and use of same
09/30/2010WO2010110408A1 Dna vaccine for alzheimer's disease
09/30/2010WO2010109924A1 Lh-type bispecific antibody
1 ... 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 ... 1823